The FDA Nanotechnology Task Force has developed several guidelines to help industry stakeholders navigate the regulatory landscape. These guidelines cover areas such as: - Characterization and measurement of nanomaterials. - Preclinical and clinical testing requirements. - Labeling and marketing considerations. - Environmental and occupational safety.
